Janux Therapeutics JANX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$24.36M+23.7% | -$31.95M-31.4% | -$24.31M+28.2% | -$33.86M-44.0% | -$23.51M-16.3% | ||
| $469K+0.2% | $468K-6.6% | $501K-7.4% | $541K+4.2% | $519K+1.4% | ||
| $9.27M-2.6% | $9.52M+5.2% | $9.04M-17.5% | $10.96M+2.4% | $10.7M+71.2% | ||
| $35M— | —— | —— | $0— | $0— | ||
| -$1.61M-197% | $1.67M+1,093% | -$168K-115% | $1.11M+168% | -$1.64M-205% | ||
| -$2.03M— | —— | $6.18M+114% | $2.89M+66.8% | $1.73M— | ||
| $1.34M+7,132% | -$19K+71.2% | -$66K+33.3% | -$99K-7.6% | -$92K-251% | ||
| $46.27M— | $0— | $0— | $0— | $0— | ||
| -$12.34M+56.8% | -$28.54M-122% | -$12.86M+46.0% | -$23.81M-39.9% | -$17.02M-1.8% | ||
| $273K+158% | $106K+14.0% | $93K-80.3% | $473K+27.5% | $371K+783% | ||
| $112.75M-8.5% | $123.28M+4.5% | $117.97M+27.3% | $92.69M-75.0% | $371.29M+1,445% | ||
| $121.31M-20.7% | $152.93M+21.0% | $126.37M+33.4% | $94.72M+203% | $31.27M-46.1% | ||
| $8.29M— | —— | —— | —— | -$340.39M— | ||
| $3.55M— | —— | —— | —— | $901K— | ||
| $3.55M+20.4% | $2.94M+497% | $493K-48.3% | $954K+72.2% | $554K-99.9% | ||
| -$506K— | $0+100% | -$4.06M+81.0% | -$21.3M+94.0% | -$356.86M-188% | ||
| $2.62M-25.5% | $3.52M-23.8% | $4.62M-11.2% | $5.21M+23.3% | $4.22M+44.2% | ||
| $469K+0.2% | $468K-6.6% | $501K-7.4% | $541K+4.2% | $519K+1.4% | ||
| $46.27M— | $0— | $0— | $0— | $0— | ||
| $36K— | —— | —— | $6K+20.0% | $5K— | ||
| $1.34M+492% | $227K— | —— | $349K-50.1% | $700K+245% | ||
| $121.31M-20.7% | $152.93M+21.0% | $126.37M+33.4% | $94.72M+203% | $31.27M-46.1% | ||
| $0— | —— | —— | —— | $347K— | ||
| $25K+125% | -$101K-287% | $54K+128% | -$190K-180% | $237K— | ||
| -$3.74M— | —— | $815K+9,156% | -$9K-101% | $1.59M— | ||
| —— | $235.75K0.0% | $235.75K0.0% | $235.75K0.0% | $235.75K— | ||
| -$12.61M+56.0% | -$28.65M-121% | -$12.95M+46.7% | -$24.29M-39.6% | -$17.4M-3.7% | ||
| -$12.61M+56.0% | -$28.65M-121% | -$12.95M+46.7% | -$24.29M-39.6% | -$17.4M-3.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Janux Therapeutics generate?
- Janux Therapeutics (JANX) generated -$77.5M in operating cash flow over the trailing twelve months.
- What is Janux Therapeutics's free cash flow?
- After $945.0K of capital expenditures, Janux Therapeutics's free cash flow was -$78.5M over the trailing twelve months, down 68.7% year over year.
- Where does Janux Therapeutics's cash flow data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
